This federal contract award, valued at $2,007.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with an ultimate completion date of December 9, 2024.
The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729.00, is for the supply of EMGALITY 120 MG/ML PENML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 2, 2024. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EMGALITY 120 MG/ML PENML, a specialty medication. The contract has a ceiling value of $1,868.28 and an ultimate completion date of March 17, 2022. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,731.84, is for the delivery of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of September 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication. The firm-fixed-price contract has a ceiling value of $1,002.72 and a period of performance through August 8, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EMGALITY 120 MG/ML PENML medication. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) with a ceiling value of $1,671.20 and an ultimate completion date of August 9, 2024. The award does not have a set-aside designation. Amerisourcebergen, through its corporate office division, will provide the medication to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,192.26 firm fixed-price delivery order is for the supply of EMGALITY 120 MG/ML PENML, a specialty medication. The contract has an ultimate completion date of November 19, 2024 and was awarded on November 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729 firm-fixed-price delivery order is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication. The contract has an ultimate completion date of November 29, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,729, is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 31, 2024. The contract is for the provision of EMGALITY 120 MG/ML PENML, a pharmaceutical product. This award is not designated as a set-aside.
Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,011.52 Firm Fixed Price Delivery Order contract is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication. The contract has an ultimate completion date of September 25, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...